Drugs Made In America Acquisition (DMAAR) EPS (2025 - 2026)
Drugs Made In America Acquisition (DMAAR) EPS from Mar 31, 2025 to Mar 31, 2026. The TTM Drugs Made In America Acquisition (DMAAR) EPS is $0.63. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Drugs Made In America Acquisition (DMAAR) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +428.75% |
Annual EPS change of Drugs Made In America Acquisition (DMAAR)
| Year | EPS | Change |
|---|---|---|
| 2026 | $0.18 | -66.84% |
| 2025 | $0.55 | N/A |